Clinical News: Page 1238

Drug-eluting stents not cost-effective if used in all patients
By Reuters Health
NEW YORK (Reuters Health), Nov 2 - In the long-term, drug-eluting stents (DES) are not a good value for the money if used in all patients with coronary artery disease, according to a report in the November 3rd issue of the Lancet.
November 1, 2007
Reuterslogo
U.S. healthcare falls short in survey of 7 nations
By Reuters Health
WASHINGTON (Reuters), Nov 2 - Americans spend double what people in other industrialized countries do on healthcare, but have more trouble seeing doctors, are the victims of more errors and go without treatment more often, according to a report released on Thursday.
November 1, 2007
Reuterslogo
Sectra wins Danish contract
By AuntMinnieEurope.com staff writers
Swedish PACS and digital mammography developer Sectra of Linköping has inked a deal with a Danish county for its Sectra MicroDose Mammography system, the company reported.
October 31, 2007
Glioblastoma survival rate quadrupled with temozolomide plus radiation
By Reuters Health
LOS ANGELES (Reuters Health), Nov 1- For the first time in approximately 30 years, a new treatment approach has improved the long-term survival rate of patients with glioblastoma. Dr. Rene-Olivier Mirimanoff presented the findings of an international team of investigators during a press conference at the 49th annual meeting of the American Society of Therapeutic Radiology and Oncology (ASTRO).
October 31, 2007
Reuterslogo
Multisection CT accurately detects coronary stent restenosis
By Reuters Health
NEW YORK (Reuters Health), Oct 31 - In-stent restenosis can be accurately assessed by 64-section CT in selected patients, according to a report in the November issue of Radiology. Dr. Jeroen J. Bax from Leiden University Medical Center, the Netherlands, and colleagues evaluated the diagnostic accuracy of 64-section CT for the assessment of in-stent or persistent restenosis in 50 consecutive patients, with conventional coronary angiography as the reference standard.
October 30, 2007
Reuterslogo
Frost report sees European autoinjector market growing
By AuntMinnieEurope.com staff writers
The European market for contrast autoinjectors produced revenues of $31.6 million in 2006, and is expected to grow to reach $60.1 million by 2013, according to a report recently issued by market research firm Frost & Sullivan.
October 30, 2007
Varian inks long-term U.K. pact
By AuntMinnieEurope.com staff writers
The London Clinic will become the first hospital in the U.K. to offer cancer treatments from Palo Alto, CA-based Varian Medical Systems' RapidArc and Trilogy technologies.
October 29, 2007
S-CAPE chooses Matrox technology
By AuntMinnieEurope.com staff writers
S-CAPE of Reichenbach, Germany, is bundling Montreal-based Matrox Graphics' Matrox Equinox graphics extension units with its medical image viewers.
October 29, 2007
Vision RT nets FDA OK and several U.S. sales
By AuntMinnieEurope.com staff writers
U.K. radiation therapy developer Vision RT has received 510(k) clearance from the Food and Drug Administration (FDA) to market its GateCT and GateRT devices in the U.S.
October 28, 2007
European Commission delays MRI usage directive
By AuntMinnieEurope.com staff writers
The European Commission has postponed for at least five years the implementation of the EU Physical Agents Directive, which was designed to protect workers from the potentially harmful effects of electromagnetic fields, including those produced by MRI systems.
October 28, 2007
Singer Watson operated on for brain tumor
By Reuters Health
LONDON (Reuters), Oct 26 - The 40-year-old tenor, who has sold millions of records around the world, was admitted to the intensive care unit at the Alexandra Hospital in Cheshire after an MRI scan found the tumor. The former factory worker from Salford, who is known as The Voice, has sold some five million albums since his first big break singing to the crowd before a football match in 1999.
October 25, 2007
Reuterslogo
Siemens gets European OK for Dade Behring buy
By AuntMinnieEurope.com staff writers
Siemens Medical Solutions announced that it has received approval by the European Commission for the acquisition of U.S.-based laboratory diagnostics company Dade Behring.
October 24, 2007
Previous Page
Page 1238 of 1288
Next Page